Trustmark National Bank Trust Department’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Trustmark National Bank Trust Department's GILD Position: Q3 2020 in Review
Trustmark National Bank Trust Department sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,670 shares — an estimated $205K sold.
Trustmark National Bank Trust Department first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $956K in Q2 2015. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Trustmark National Bank Trust Department reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Trustmark National Bank Trust Department sold 2,670 Gilead Sciences shares in Q3 2020, an estimated $205K.
- Trustmark National Bank Trust Department first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
- Trustmark National Bank Trust Department's Gilead Sciences position peaked at $956K in Q2 2015.
- 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Trustmark National Bank Trust Department's 13F filing for Q3 2020, filed 13 Nov 2020.